Cellusion Inc.

Cellusion Inc. ...

Cellusion Inc. is a company in medical engineering & biotechnology based in Asia-Pacific (APAC), founded in 2015.

Profile

"Cellusion is a pioneering medtech company focused on developing corneal endothelial regenerative medicine to enhance global visibility in the Japanese healthcare industry. With a vision to contribute to the advancement of next-generation regenerative medicine, Cellusion aims to address three key challenges in traditional corneal transplant treatments. By mass-producing corneal endothelial cells from iPS cells and utilizing cell injection therapy for transplantation, Cellusion simplifies and shortens surgical procedures. This innovative approach reduces invasiveness compared to conventional transplant treatments, alleviating patient burden. By utilizing allogeneic iPS cells, Cellusion eliminates the need for eye banks and facilitates easy access to pharmaceutical products for patients. Through these advancements, Cellusion offers innovative solutions in regenerative medicine to enhance the quality of life for patients worldwide."

Cellusion Inc. is positioned in medical engineering & biotechnology, a segment that rewards a clear, focused offering.

The business is associated with Asia-Pacific (APAC).

Directory data places it at the Series_C stage.

Its team size is recorded as c_00011_00050 employees.

Public records show total funding of about $4.4B.

Website: cellusion.jp